US 11,857,430 B2
Interbody implants and optimization features thereof
Collin Newman, Wayne, NJ (US); Christian Karl Schultz, Hoboken, NJ (US); Steven Willis, Midland Park, NJ (US); Amir Ali Sharifi-Mehr, Bloomingdale, NJ (US); Oliver Buchert, Franklin Lakes, NJ (US); Christopher P. Bell, New York, NY (US); Andrew Edward Ehlers, Monroe, NY (US); Anna Reza, Montclair, NJ (US); Marc Gilles Long, Denville, NJ (US); and Joseph Henry Robinson, New City, NY (US)
Assigned to Stryker European Operations Holdings LLC, Kalamazoo, MI (US)
Filed by Stryker European Operations Holdings LLC, Kalamazoo, MI (US)
Filed on Jun. 22, 2021, as Appl. No. 17/353,988.
Application 17/353,988 is a continuation of application No. 16/535,524, filed on Aug. 8, 2019, granted, now 11,065,126.
Claims priority of provisional application 62/716,448, filed on Aug. 9, 2018.
Prior Publication US 2021/0307921 A1, Oct. 7, 2021
This patent is subject to a terminal disclaimer.
Int. Cl. A61F 2/44 (2006.01); A61F 2/46 (2006.01); A61F 2/28 (2006.01)
CPC A61F 2/442 (2013.01) [A61F 2/4455 (2013.01); A61F 2/4611 (2013.01); A61F 2/2846 (2013.01); A61F 2002/2835 (2013.01); A61F 2002/4629 (2013.01); A61F 2250/0018 (2013.01); A61F 2310/00023 (2013.01)] 19 Claims
OG exemplary drawing
 
1. A spinal interbody device (IBD), comprising:
a solid structure; and
a porous body, including a plurality of sections of different porosity than an adjacent section, connected to the solid structure and being defined by a plurality of adjoining cells and pores situated between the cells.